title: Markedly increased plasma (1-->3)-beta-D-glucan is a diagnostic and therapeutic indicator of Pneumocystis carinii pneumonia in a non-AIDS patient.
authors.forename: S
authors.initials: S
authors.lastname: Teramoto
authors.forename: D
authors.initials: D
authors.lastname: Sawaki
authors.forename: S
authors.initials: S
authors.lastname: Okada
authors.forename: Y
authors.initials: Y
authors.lastname: Ouchi
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use; D005260:Female; D005936:Glucans / Q000097:blood*; D006801:Humans; D016867:Immunocompromised Host; D008875:Middle Aged; D011020:Pneumonia, Pneumocystis / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use; D047071:beta-Glucans
chemical_list: D000890:Anti-Infective Agents; D005936:Glucans; D047071:beta-Glucans; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; C033363:beta-1,3-glucan